Kinetic analysis of zinc ligand mutants of mammalian protein farnesyltransferase

被引:42
作者
Fu, HW
Beese, LS
Casey, PJ [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
关键词
D O I
10.1021/bi972511c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein farnesyltransferase (FTase) is a zinc metalloenzyme that catalyzes the prenylation of several proteins that are important in cellular regulatory events. A specific residue of FTase, Cys299 in the p beta subunit previously identified as essential for zinc binding and catalysis, had been tentatively assigned as one of the zinc ligands. This assignment was subsequently confirmed in the X-ray structure of FTase, which also identified two additional residues, Asp297 and His362 in the beta subunit, as the remaining protein-derived metal ligands. To more fully explore the role of zinc in the catalytic mechanism of FTase, site-directed mutagenesis was performed on these two zinc ligands. Although the abilities of all the mutants to bind the farnesyl diphosphate substrate were similar to that of the wild-type enzyme, all the mutants displayed markedly reduced enzymatic activities and zinc affinities. Steady-state and pre-steady-state kinetic analyses of the residual activities indicated that the rate-limiting step changed from product release in the wild-type enzyme to the chemical step of product formation for three of the mutant enzymes. Additionally, single-turnover experiments indicated that the greatest effect of alteration of zinc ligands for all the mutants was on the product formation step, this being reduced 10(3)-10(5)-fold in the mutant forms compared to the wild-type enzyme. These results confirm a critical involvement of the zinc in catalysis by FTase and support a model in which the metal ion is directly involved in the chemical step of the enzymatic reaction.
引用
收藏
页码:4465 / 4472
页数:8
相关论文
共 36 条
[1]   Farnesyl transferase inhibitors: The successes and surprises of a new class of potential cancer chemotherapeutics [J].
Buss, JE ;
Marsters, JC .
CHEMISTRY & BIOLOGY, 1995, 2 (12) :787-791
[2]   Protein prenyltransferases [J].
Casey, PJ ;
Seabra, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) :5289-5292
[3]   ENZYMATIC MODIFICATION OF PROTEINS WITH A GERANYLGERANYL ISOPRENOID [J].
CASEY, PJ ;
THISSEN, JA ;
MOOMAW, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8631-8635
[4]   Transition state analogs for protein farnesyltransferase [J].
Cassidy, PB ;
Poulter, CD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (36) :8761-8762
[5]  
CHEN WJ, 1993, J BIOL CHEM, V268, P9675
[7]   A MECHANISM FOR POSTTRANSLATIONAL MODIFICATIONS OF PROTEINS BY YEAST PROTEIN FARNESYLTRANSFERASE [J].
DOLENCE, JM ;
POULTER, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :5008-5011
[8]   Yeast protein farnesyltransferase. Site-directed mutagenesis of conserved residues in the beta-subunit [J].
Dolence, JM ;
Rozema, DB ;
Poulter, CD .
BIOCHEMISTRY, 1997, 36 (30) :9246-9252
[9]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[10]   Identification of a cysteine residue essential for activity of protein farnesyltransferase - Cys(299) is exposed only upon removal of zinc from the enzyme [J].
Fu, HW ;
Moomaw, JF ;
Moomaw, CR ;
Casey, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (45) :28541-28548